VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 168 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,416,000 | +18.6% | 298,605 | +7.4% | 0.23% | -2.1% |
| Q1 2020 | $2,881,000 | +18.6% | 278,100 | +87.9% | 0.24% | +13.3% |
| Q4 2019 | $2,429,000 | +22.6% | 148,000 | -0.8% | 0.21% | +15.9% |
| Q3 2019 | $1,981,000 | +16.2% | 149,139 | +23.3% | 0.18% | +17.4% |
| Q2 2019 | $1,705,000 | +157.9% | 120,998 | +236.7% | 0.16% | +142.2% |
| Q1 2019 | $661,000 | +159.2% | 35,934 | +268.1% | 0.06% | +73.0% |
| Q4 2018 | $255,000 | -21.8% | 9,763 | -49.5% | 0.04% | -5.1% |
| Q1 2018 | $326,000 | – | 19,346 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |